Labeling proteins with fluorine-18 using N-succinimidyl 4-[18F]fluorobenzoate
-
Add time:08/24/2019 Source:sciencedirect.com
Two methods were investigated for the no-carrier-added synthesis of N-succinimidyl 4-[18F]fluorobenzoate (S[18F]FB). The first, an attempted nucleophilic aromatic substitution by [18F]fluoride on N-succinimidyl 4-nitrobenzoate was unsuccessful. The second method involved three steps; [18F]fluoride for trimethylammonium substitution on 4-formyl-N,N,N-trimethylanilinium triflate, oxidation to 4-[18F]fluorobenzoic acid, followed by reaction with N-hydroxysuccinimide and dicyclohexylcarbodiimide to form S[18F]FB. Total synthesis and purification time was 100 min and the overall radiochemical yield was 25% (decay corrected). A monoclonal antibody F(ab′)2 fragment could be labeled in 40–60% yield by reaction with S[18F]FB for 15–20 min. The tissue distribution in normal mice and in vitro tumor binding of the antibody F(ab′)2 labeled by reaction with S[18F]FB were comparable to those observed for the fragment after radioiodination using N-succinimidyl 4-[125I]iodobenzoate.
We also recommend Trading Suppliers and Manufacturers of N-succinimidyl 4-(tri-n-butylstannyl)benzoate (cas 107759-58-0). Pls Click Website Link as below: cas 107759-58-0 suppliers
Prev:Optimization of a convenient route to produce N-succinimidyl 4-radiodobenzoate for radioiodination of proteins
Next:Radiobromination of humanized anti-HER2 monoclonal antibody trastuzumab using N-succinimidyl 5-bromo-3-pyridinecarboxylate, a potential label for immunoPET) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Radiobromination of humanized anti-HER2 monoclonal antibody trastuzumab using N-succinimidyl 5-bromo-3-pyridinecarboxylate, a potential label for immunoPET08/25/2019
- Optimization of a convenient route to produce N-succinimidyl 4-radiodobenzoate for radioiodination of proteins08/23/2019
- Radiopharmaceutical chemistry of targeted radiotherapeutics, part 4: Strategies for 211At labeling at high activities and radiation doses of 211At α-particles08/22/2019
- Optimized indirect 76br-bromination of antibodies using n-succinimidyl para-[76br]bromobenzoate for radioimmuno PET08/21/2019
- Synthesis of 125I labeled N-succinimidyl p-iodobenzoate for use in radiolabeling antibodies08/20/2019
- Synthesis of N-succinimidyl-2,4-dimethoxy-3-(tri-N-butylstannyl) benzoate via regio-specifically generated lithium 2,4-dimethoxy-3-lithiobenzoate08/19/2019
- Synthesis of radioiodinated N-succinimidyl iodobenzoate: Optimization for use in antibody labelling☆08/18/2019
- Astatination of proteins using an N-succinimidyl tri-n-butylstannyl benzoate intermediate☆08/17/2019
- N-Succinimidyl 4-methyl-3-(tri-n-butylstannyl)benzoate: Synthesis and potential utility for the radioiodination of monoclonal antibodies08/16/2019
-
Health and Chemical more >


